...from the attached NIH article...
---------------------
Monday, March 16, 2020
NIH clinical trial of investigational vaccine for COVID-19 begins
A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is funding the trial. KPWHRI is part of NIAID’s Infectious Diseases Clinical Research Consortium. The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks. The first participant received the investigational vaccine today.
The study is evaluating different doses of the experimental vaccine for safety and its ability to induce an immune response in participants. This is the first of multiple steps in the clinical trial process for evaluating the potential benefit of the vaccine.
The vaccine is called mRNA-1273 and was developed by NIAID scientists and their collaborators at the biotechnology company Moderna, Inc., based in Cambridge, Massachusetts. The Coalition for Epidemic Preparedness Innovations (CEPI) supported the manufacturing of the vaccine candidate for the Phase 1 clinical trial.
“Finding a safe and effective vaccine to prevent infection with SARS-CoV-2 is an urgent public health priority,” said NIAID Director Anthony S. Fauci, M.D. “This Phase 1 study, launched in record speed, is an important first step toward achieving that goal.”
Infection with SARS-CoV-2, the virus that causes COVID-19, can cause a mild to severe respiratory illness and include symptoms of fever, cough and shortness of breath. COVID-19 cases were first identified in December 2019 in Wuhan, Hubei Province, China. As of March 15, 2020, the World Health Organization (WHO)(link is external) has reported 153,517 cases of COVID-19 and 5,735 deaths worldwide. More than 2,800 confirmed COVID-19 cases and 58 deaths have been reported in the United States as of March 15, according to the Centers for Disease Control and Prevention (CDC)(link is external).
-----------------
Now here's Moderna's timeline for developmenet of the mRNA-1273 vaccine...
https://www.researchgate.net/figure/Timeline-of-Modernas-mRNA-1273-vaccine-development-for-COVID-19-11-27_fig2_358429330
Note again that Tony Fauci was the Director of NIAID, the agency who's scientists worked with Moderna in the development of its successful vaccine...he spearheaded the whole program...while DJT was still calling SARS-CoV-2 (COVID-19) a "Hoax" that would later just "Go Away" by Easter.
Thanks to Dr. Fauci, the NIAID team and Moderna were ready to start development and testing as soon as the COVID genome was received in January, 2020...
It's no trouble whatsoever heaping praise on Dr. Fauci...and scorn on Donald Trump.
Link: https://www.nih.gov/news-events/news-releases/nih-clinical-trial-investigational-vaccine-covid-19-begins